Position in NBIX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$15,399,668
-$999,195 QoQ
Shares Held
91,371
-26.6% QoQ
Ownership
0.090%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#126
of 768 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026LAZARD ASSET MANAGEMENT LLC holds $122,207,057 across 17 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (12.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
945,784 | $67,964,038 | |
| 2 | RDY |
Dr Reddys Laboratories Ltd
|
1,231,678 | $17,847,014 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
This page
|
91,371 | $15,399,668 | |
| 4 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
67,291 | $4,303,259 | |
| 5 | PAHC |
Phibro Animal Health Corp
|
130,438 | $4,095,753 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
34,396 | $3,815,892 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
95,219 | $2,343,339 | |
| 8 | TLRY |
Tilray Brands, Inc.
|
394,715 | $1,772,270 |
All Filings in NBIX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,399,668 | 91,371 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $16,398,863 | 124,479 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $9,208,312 | 64,925 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $5,738,313 | 40,877 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,571,847 | 36,374 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $6,280,089 | 56,782 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $8,091,583 | 59,279 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $8,632,511 | 74,922 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $8,457,480 | 61,433 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $7,630,975 | 55,329 | Shares | Sole | 2024-07-09 | |
| 2023-12-31 | $6,119,593 | 46,445 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,065,962 | 27,253 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $175,398 | 1,860 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $4,553,583 | 44,987 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $505,828 | 4,235 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $127,770 | 1,203 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $74,572 | 765 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $74,156 | 791 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $4,131,426 | 48,508 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $3,271,873 | 34,114 | Shares | Sole | 2021-11-15 | |
| 2021-03-31 | $88,983 | 915 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $94,699 | 988 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $92,313 | 960 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $142,984 | 1,172 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $156,915 | 1,813 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||